You have decided, with your doctor, that an FDA-approved option is worth exploring. Maybe you already know the name Spravato. Maybe you just know you want something with a regulator's sign-off and a real chance of insurance paying for it. Either way, the next job is finding a place that can actually provide it, takes your plan, and is close enough to reach.
This guide walks through that search for people with commercial insurance, wherever you live.
Why the FDA filter is worth using
You are not alone in wanting it. Our publisher funded a survey across ten Midwest states, and of its 443 adult respondents, 59 percent rated FDA approval as either a big factor or the deciding one when weighing a new depression treatment. Those are final, validated figures; people on commercial coverage, 173 in all, came in lower at 54 percent.
For commercially insured patients, the filter also has a practical payoff. Insurers generally have a clearer coverage path for FDA-approved treatments used for their approved purpose. That does not ensure coverage, but it usually means there is a defined process to follow.
Know which treatment you are searching for
When the usual medicines have not done enough, the options people ask about sit in separate regulatory categories:
- Esketamine (Spravato): an FDA-approved nasal spray indicated for depression other treatments have not relieved, used only in certified settings, where each visit ends with a supervised wait of two hours or longer. You can read how Brain Recovery Centers runs Spravato visits.
- TMS: A device, not a drug, cleared by the FDA for depression that antidepressants have not budged.
- IV ketamine: Ketamine's approval is for anesthesia; treating depression with it is off-label.
- At-home ketamine: Not FDA-approved for depression.
This guide focuses mostly on esketamine, since it is the one ketamine-family drug with FDA approval and comes with the strictest rules about where it can be given. Much of the same process applies to TMS.
Step 1: Get the clinical green light first
Before you search, confirm with your doctor or psychiatrist that the treatment is reasonable for you and that your history matches the approved use. Insurers usually want records of the antidepressants you have tried. Suitability is a clinical decision, and starting there saves wasted calls.
Most people start in exactly this place. Our survey found 56 percent would begin with their primary care doctor, while 23 percent would skip ahead and book a psychiatrist.
Step 2: Find certified treatment centers
Because esketamine can only be given in certified settings, not every psychiatry office can offer it. Ways to find ones near you:
- Ask your doctor whether they refer to a certified center they trust.
- Use the treatment center search on the manufacturer's website, which lists certified locations.
- Check with the psychiatry department of the nearest large hospital system or academic medical center.
For TMS, search your insurer's directory for "transcranial magnetic stimulation" as a service.
Step 3: Cross-check against your plan
A center being certified and a center being in your network are two different things. Log in to your insurer's provider directory, or call member services, and confirm the specific location is in network. Then ask the plan for its medical or pharmacy policy on esketamine so you know the approval criteria.
Coverage is not a side issue for most people. Asked to name two things they want most from a provider, 85 percent of respondents listed insurance coverage. More than half said they would accept extra hoops to stay covered rather than pay out of pocket to move faster.
Step 4: Call the center and ask the right questions
Once you have one or two candidates, a phone call goes a long way:
- "Are you certified to administer Spravato?"
- "Are you in network with my plan for both the medication and the office visit?"
- "Does my plan route the drug through your office or a specialty pharmacy?"
- "Is it your office or the clinic that sends the prior authorization, and how long do insurers usually sit on it?"
- "What will my share be per visit, and for the first two months?"
- "Can you tell me about the manufacturer's savings program and what it covers?"
The drug and the monitored visit are often billed separately. Knowing how your plan handles each prevents surprises.
Step 5: Weigh distance realistically
Esketamine usually runs two sessions a week during month one, tapering to weekly or less after that. Driving is off the table after each dose until a night's sleep has passed, so someone has to take you home. A center an hour away is a four-hour round trip for your driver, twice a week.
Of those we surveyed, 43 percent ranked a location near home among their top two needs, and for a treatment with this rhythm, it can decide whether a course is sustainable. The same survey found that 44 percent would prefer an in-person clinic, which fits a treatment that can only be given in one.
If you commute, consider a center near work, but factor in that you will need a ride home from there too.
Step 6: Watch for red flags
Be cautious if a clinic:
- Promises results, or quotes a figure for how often it works as if it were certain.
- Pushes you to pay in full before verifying your benefits.
- Describes an off-label or compounded product as "FDA-approved."
- Skips a psychiatric evaluation or does not ask about your history.
A final word
An FDA-approved treatment at an in-network clinic near home is a strong starting point, but it is not a promise of results. The question of fit belongs to a clinician holding your full history. This guide is general information, not medical advice.
If you are thinking about suicide, do not wait until the search is done. Text or call 988 while you keep looking; wherever you are in the country, a trained Suicide and Crisis Lifeline listener takes the call, day or night, while your clinic search waits.
Methodology
Pollfish fielded this survey for us, ending collection on June 23, 2026, holding 443 finished questionnaires. Every participant was 18 to 64, living in Indiana, Kansas, Wisconsin, Oklahoma, Illinois, Nebraska, Minnesota, Missouri, Ohio, and Iowa. Besides the commercial plan figure, numbers describe everyone surveyed, and validation of the panel is complete. Our publisher commissioned this survey, then paid Pollfish to run it.